Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Verona Pharma Q3 EPADS $(0.16) Beats $(0.28) Estimate; Cash Position Of $257.4M

Author: Benzinga Newsdesk | November 02, 2023 03:21am

Verona Pharma (NASDAQ:VRNA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.28) by 42.86 percent. This is a 30.43 percent increase over losses of $(0.23) per share from the same period last year.

Cash and cash equivalents at September 30, 2023, were $257.4 million

Posted In: VRNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist